• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Targeting a Brain Enzyme to prevent Obesity

Raja Aditya by Raja Aditya
2 years ago
in Healthcare & Medicine, Science News
0
Obesity

Targeting a Brain Enzyme to prevent Obesity | Neo Science Hub

Food intake and energy utilization are significantly influenced by endocannabinoids in the brain. Researchers from the University of Montreal affiliated hospital research center (CRCHUM) believe that altering the way these molecules function could aid in the fight against obesity.

According to the source, Stephanie Fulton, a medical professor at the University of Montreal, and her colleagues have spent years figuring out how the human neurological system regulates hunger, physical activity, and mood, as well as how metabolism impacts mood. Their most recent finding, which was reported in Nature Communications, expands on that understanding.

First co-authors Stephanie Tobin, a former postdoctoral fellow, and David Lau, a doctoral student at the University of Montreal, demonstrate in their study that neurons in the nucleus accumbens, a part of the brain rich in endocannabinoids that aids in controlling food reward and physical activity, strongly modulate body-weight control in mice.

2-arachidonoylglycerol (2-AG), a crucial endocannabinoid molecule, is broken down in the brain by the enzyme ABHD6. When the team led by Marc Prentki, a researcher at the CRCHUM, discovered in 2016 that whole-body inhibition of ABHD6 decreased body weight and prevented diabetes, it raised the question of what this enzyme does in the brain to influence appetite and body weight.

Fulton stated, “There was less motivation for food and greater interest in physical activity when we deleted the gene encoding ABHD6 in the nucleus accumbens in mice. This was a surprising discovery as we expected that increasing 2-AG levels would stimulate food intake by increasing cannabinoid signaling.”

“In contrast to the control group, which grew fat and listless, the mice choose to spend more time on a running wheel.” Her team was able to fully shield mice against weight gain and obesity by injecting a specific ABHD6 inhibitor into their brains.

Can have opposite effects

Today’s scientists must be able to target particular brain neural pathways in order to regulate weight. The consequences of blocking ABHD6 can vary depending on the part of the brain that is being targeted.

In 2016, Fulton and Thierry Alquier, a colleague at CRCHUM, demonstrated that mice were resistant to weight loss when ABHD6 was blocked in specific hypothalamus neurons.

However, the authors of the new study demonstrate that inhibiting this chemical throughout the brain reduces weight gain when following a high-fat diet.

No signs of anxiety

According to Fulton, “we also demonstrate in our study that mice with the ABHD6 gene suppressed do not exhibit indications of anxiety and depressive behaviour.”

This is significant since the weight-loss medication Rimonabant, which targeted cannabinoid receptors in the central nervous system, was taken off the market in the late 2000s after users had severe side effects, including suicidal thoughts and despair.

According to the scientists, Fulton’s team’s most recent research paves the path for treatments to combat metabolic diseases like type 2 diabetes and obesity.

It is unknown if the pathways the researchers are targeting in mice will be the same in people while ABHD6 pharmacological inhibitors are being evaluated.

-NSH Digidesk

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: ABHD6brainDiabetesendocannabinoidsfeaturedObesityphysical activitysciencenews
Raja Aditya

Raja Aditya

Associate Editor for Neo Science Hub Magazine

Other Posts

Young maize in paired rows on raised beds with water in the furrows between them

Lifting the Crop Off the Floor: Why Raised Beds Are Gaining Ground in a Water-Short Country

November 15, 2026 - Updated on November 16, 2026
3
Trays of green and purple microgreens beside a field being sprayed

Small Leaves, Small Particles: Microgreens Have the Evidence. Nano-Urea Is Still Earning It

November 15, 2026 - Updated on November 16, 2026
4

A Crore and a Half Recharge Pits Later: What India’s Water Reforms Can, and Cannot, Teach the Global South

A Purple Broccoli That Seeds in Delhi and a Sponge Gourd That Shrugs Off a Virus

Fourteen Seconds to 241 km/h and Back: What a Runway Test Says About Where Car Performance Now Lives

An Aeroplane on a Helipad: What Electra’s Manhattan Landing Proves, and What It Does Not

After the Space Station: NASA Opens the Contest to Become a Tenant in Orbit

At 94, the Air Force Counts Its Squadrons, and Waits for an Engine India Can Call Its Own

Next Post
Vaccine

Russia develops a Cancer Vaccine to be distributed for free

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
8

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist